Correlation Between Zenas BioPharma, and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Zenas BioPharma, and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenas BioPharma, and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenas BioPharma, Common and Terns Pharmaceuticals, you can compare the effects of market volatilities on Zenas BioPharma, and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenas BioPharma, with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenas BioPharma, and Terns Pharmaceuticals.
Diversification Opportunities for Zenas BioPharma, and Terns Pharmaceuticals
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Zenas and Terns is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Zenas BioPharma, Common and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Zenas BioPharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenas BioPharma, Common are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Zenas BioPharma, i.e., Zenas BioPharma, and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Zenas BioPharma, and Terns Pharmaceuticals
Given the investment horizon of 90 days Zenas BioPharma, Common is expected to under-perform the Terns Pharmaceuticals. In addition to that, Zenas BioPharma, is 1.83 times more volatile than Terns Pharmaceuticals. It trades about -0.33 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.08 per unit of volatility. If you would invest 688.00 in Terns Pharmaceuticals on August 30, 2024 and sell it today you would lose (54.00) from holding Terns Pharmaceuticals or give up 7.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zenas BioPharma, Common vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Zenas BioPharma, Common |
| Terns Pharmaceuticals |
Zenas BioPharma, and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zenas BioPharma, and Terns Pharmaceuticals
The main advantage of trading using opposite Zenas BioPharma, and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenas BioPharma, position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Zenas BioPharma, vs. Dogwood Therapeutics, | Zenas BioPharma, vs. Enliven Therapeutics | Zenas BioPharma, vs. Enlivex Therapeutics | Zenas BioPharma, vs. Entero Therapeutics, |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |